MicroRNA implication in urinary bladder cancer A. Zaravinos 1, J. Radojicic 3, G.I. Lambrou 2, D. Volanis 1,4, D. Delakas 4, E.N. Stathopoulos 3, D.A.

Slides:



Advertisements
Similar presentations
Pancreatic Islets within Pancreas. Modulators of Insulin Secretion.
Advertisements

Viral and Cellular MicroRNAs as Determinants of Viral Pathogenesis and Immunity Role of miRNAs in interaction between viruses and their hosts Ines Hahn,
Improving miRNA Target Genes Prediction Rikky Wenang Purbojati.
Author: Jim C. Huang etc. Lecturer: Dong Yue Director: Dr. Yufei Huang.
Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs LEE P. LIM, NELSON C. LAU, PHILIP GARRETT-ENGELE ANDREW GRIMSON,
Presenting: Asher Malka Supervisor: Prof. Hermona Soreq.
MicroRNA Target Prediction Using Muscle Atrophy Genes As Models Caltech Wold Lab Mentors: Dr. Barbara Wold Diane Trout Brandon King Gilberto Hernandez,
 MicroRNAs (miRNAs) are a class of small RNA molecules, about ~21 nucleotide (nt) long.  MicroRNA are small non coding RNAs (ncRNAs) that regulate.
Genetic Alterations of TP53 Gene in Brain Astrocytic Tumours Methodology Θ Eighty-three brain tumor biopsies were collected and used in this study. Thirty.
“Discovery Of Gene Ripple Effect Which Causes Cervical Cancer to Advance And Spread” May 19 th, 2011
A 14-gene prognosis signature predicts metastasis risk in node-negative, estrogen receptor-positive, Tamoxifen-treated breast cancer in different ethnogeographic.
Jingfu wang The role of WT1 gene in neuroblastoma Department of Pediatric Oncology Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin.
Transcription Factor Binding Motifs, Chromosome mapping and Gene Ontology analysis on Cross-platform microarray data from bladder cancer. Apostolos Zaravinos.
Molecular classification of renal cell carcinoma subtypes using microRNA signatures Zaravinos A 1, Lambrou GI 2, Mourmouras N 3, Delakas D 3, Deltas C.
Introduction Hepatitis C Virus
MiR-19b/20a/92a regulates the self- renewal and proliferation of gastric cancer stem cells Journal of Cell Science (IF=5.325) 报告人:黄美玲
Miki Fuse 1, Satoko Kojima 2, Takeshi Chiyomaru 3, Hideki Enokida 3, Kazumori Kawakami 3, Hirofumi Yoshino 3, Nijiro Nohata 1, Yukio Naya 2, Tomohiko Ichikawa.
Huidi Liu, M.D. & Ph.D Genomics Research Centre Harbin Medical University, China Reduced expression of SOX7 in ovarian cancer: a novel.
Invitrogen Corporation 1600 Faraday Ave. Carlsbad, CA USA Tel: FAX: Toll Free Tel:
吳 華 席 Hua-Hsi Wu, MD OB/GYN, VGH-TPE Aug 12, 2008
Marco Magistri , Journal Club. A non-coding RNA (ncRNA) is any RNA molecule that is not translated into a protein “Structural genes encode proteins.
Apostolos Zaravinos and Constantinos C Deltas Molecular Medicine Research Center and Laboratory of Molecular and Medical Genetics, Department of Biological.
SmallRNAs Small molecules, big functions. Brief history The first described microRNA, lin-4 was cloned and characterised as a translational repressor.
OncomiR and tumor-suppressor miR expression in triple-negative primary breast cancer. Jelena Radojicic 1, Apostolos Zaravinos 2, Thomas Vrekoussis 1, Maria.
The tumour suppressor RhoB is an independent prognostic factor for metastasis in urinary bladder cancer. Apostolos Zaravinos 1, Dimitrios Volanis 1,2,
Cross-platform comparisons of microarray data. Elucidation of common differentially expressed genes in bladder cancer. Apostolos Zaravinos 1, George I.
MiR-21 can be used as independent prognostic factor for survival and metastasis in urinary bladder cancer. Apostolos Zaravinos 1, Jelena Radojicic 3, George.
Improving Intergenic miRNA Target Genes Prediction Rikky Wenang Purbojati.
ICNCT-16, June 2014, Helsinki Glioma heterogeneity and the L-Amino acid transporter-1 (LAT1): A first step to stratified BPA-based BNCT? D. Ngoga 1 ; C.
RNA-ligand interactions and control of gene expression
Dr. Jeyaparvathi Somasundaram
Establishment and verification of miRNAs expression molecules for breast cancer and its distant metastasis Yanhong Gao Associate Professor Department of.
NCode TM miRNA Analysis Platform Identifies Differentially Expressed Novel miRNAs in Adenocarcinoma Using Clinical Human Samples Provided By BioServe.
-33 Red bar: tonsil tumour samples, n =14 x2 Green bar: tonsil normal samples, n = 9 x2 A B Supplementary Figure 1. A)Unsupervised HCL analysis was used.
Expression profile of oncomiRs and tumor-suppressor miRs in urothelial carcinoma of the bladder Apostolos Zaravinos 1, George I. Lambrou 2, Jelena Radojicic.
Growth factor PI3K PDK1/2 PIP 3 AKT CASP9 FOXO1 BAD CDKN1A CDKN1B MDM2 GSK3B CHUK mTOR PTEN miR-26ab/1297; miR-148/152; miR-103/107; miR-19; miR-425/489;
Date of download: 6/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Novel Integrative Methods for Gene Discovery Associated.
Mestrado Integrado em Medicina Biologia Celular e Molecular II
Date of download: 7/10/2016 Copyright © 2016 McGraw-Hill Education. All rights reserved. Basic steps of gene expression—transcription factors regulate.
Yuna Jo. Introduction Prostate cancer (PCa) continues to burden the Western world with its high rates of incidence and mortality despite the.
miRNA-targets cross-talks: key players in glioblastoma multiforme
MicroRNA-34a: a key regulator in the hallmarks of renal cell carcinoma
Figure 1. miRNA in NETs PNET SB-NET miR-7-5p miR-19a miR-96 miR-182
Fig. 1 Increased MIR155HG expression correlates with glioma grade and mesenchymal transition and confers a poor prognosis in GBM patients. (A) The level.
Figure Legend: From: Noncoding RNAs:New Players in Chronic Pain
Tel: Serum microRNA-21: a promising diagnostic and prognostic biomarker in Egyptian breast cancer patients.
MicroRNA-101 Inhibits Growth, Proliferation and Migration and Induces Apoptosis of Breast Cancer Cells by Targeting Sex-Determining Region Y-Box 2 Cell.
Integrated microRNA-mRNA profiling identifies molecular biomarkers in bladder outlet obstruction-induced lower urinary tract dysfunction Fiona C. Burkhard1,
Interpretation of Results
? miRNA profiling (primary vs recurrent) Between patients cohort (n=6)
Figure 1 miRNA expression in multiple sclerosis lesions
Long Noncoding RNA in Prostate, Bladder, and Kidney Cancer
2018/03/18 外科年會 Oral Presentation
MicroRNA in Prostate, Bladder, and Kidney Cancer: A Systematic Review
MicroRNA-489 Plays an Anti-Metastatic Role in Human Hepatocellular Carcinoma by Targeting Matrix Metalloproteinase-7  Yixiong Lin, Jianjun Liu, Yuqi Huang,
Characterization of microRNA transcriptome in tumor, adjacent, and normal tissues of lung squamous cell carcinoma  Jun Wang, MD, PhD, Zhi Li, MD, PhD,
UHRF1 is regulated by miR-9 in colorectal cancer
MicroRNAs: regulators of gene expression and cell differentiation
C. Belair, F. Darfeuille, C. Staedel 
Learning More from Microarrays: Insights from Modules and Networks
Volume 135, Issue 1, Pages (July 2008)
mRNA Degradation and Translation Control
The High Expression of the microRNA 17–92 Cluster and its Paralogs, and the Downregulation of the Target Gene PTEN, Is Associated with Primary Cutaneous.
Epigenetics modification
MiRNA Profiling Identifies Candidate miRNAs for Bladder Cancer Diagnosis and Clinical Outcome  Nadine Ratert, Hellmuth-Alexander Meyer, Monika Jung, Poline.
MicroRNAs in cancer: biomarkers, functions and therapy
Treated with Neoadjuvant Therapy
Long Noncoding RNA BC as a Novel Therapeutic Target for Colorectal Cancer that Suppresses Metastasis by Upregulating TIMP3  Jiaxin Lin, Xin Tan,
MicroRNAs in cancer: biomarkers, functions and therapy
Correlation of miR-21 expression levels with DEGs in 28 bladder cancer cell lines. Correlation of miR-21 expression levels with DEGs in 28 bladder cancer.
Presentation transcript:

microRNA implication in urinary bladder cancer A. Zaravinos 1, J. Radojicic 3, G.I. Lambrou 2, D. Volanis 1,4, D. Delakas 4, E.N. Stathopoulos 3, D.A. Spandidos 1 1 Laboratory of Virology, Medical School, University of Crete, Heraklion, Crete, Greece. 2 1 st Department of Pediatrics, Choremeio Research Laboratory, University of Athens, Athens, Greece. 3 Department of Surgical Pathology, Medical Faculty, University of Crete, Heraklion, Crete, Greece. 4 Department of Urology, Asklipieio General Hospital, Voula, Athens, Greece. Urinary bladder cancer is the most common malignancy of the urinary tract, responsible for significant mortality and morbidity worldwide. MicroRNAs (miRNAs) are a group of endogenous, small, noncoding RNA molecules of ~22 nucleotides. The interaction of miRNAs and target genes is intricately regulated, in that one miRNA may modulate multiple target genes whereas one target gene may be regulated by various miRNAs. MiRNAs negatively affect the expression level of their target genes through two distinctive mechanisms, depending on the degree of their complementarity to target sequences. In the first mechanism, a perfect or near-perfect match between miRNAs and their binding sequences within the 3’ untranslated regions (UTR) of their target mRNAs induces the RNA-mediated interference pathway. The RNA-induced silencing complex then recognizes the miRNA-mRNA interaction and cleaves the mRNA through an endonuclease activity. In the second mechanism, miRNAs control gene expression at the translational level through imperfect target matching. MiRNAs influence tumorigenesis through their regulation of specific proto-oncogenes and tumor suppressor genes. Figure 1. ROC curve analysis. miR-145, miR-221 and miR p had the best sensitivity and specificity to distinguish urinary bladder cancer from control samples. Seventy-seven urinary BC cases, along with 77 matched tumor-associated normal samples were investigated for the expression of 11 miRNAs using qPCR. The relationship among the expression of miR-10b, miR-19a, miR-19b, miR-21, miR-126, miR-145, miR-205, miR-210, miR-221, miR p and miR-378-1, as well as with the pathologic features of the tumors, was further examined. The influence of miR expression on the overall and cancer-specific survival of the patients, as well as putative target genes of the up- and down-regulated miRNAs were also predicted. As expected, the majority of the microRNAs studied (miR-10b, miR-145, miR-221, miR-296-5p and miR-378) exhibited significant down-regulation in BC vs. the normal tissue (Table 1). A great range in the x-fold expression values of all microRNAs was noticed. miR-145 was found to be the most down-regulated in bladder cancer compared with normal, and miR-205, miR-210 and miR-21 were the most up-regulated in cancer. High expression of miR-21 correlated with worse overall survival (p=0.0099) (Figure 2). Univariate analysis showed that miR-21 and miR-210 can be used as independent prognostic factors for overall survival (p=0.015 and p=0.049, respectively). Moreover, univariate analysis revealed that miR- 21 can be used as independent prognostic factor for metastasis (p=0.049). Multivariate analysis revealed that miR-21, miR-210 and miR-378 can be used as independent prognostic factors for overall survival (p=0.005, p=0.033 and p=0.012, respectively); miR-21 and miR-378 can be used as independent prognostic factors for recurrence (p=0.030 and p=0.031, respectively); and miR-21 can be used as independent prognostic factors for metastasis (p=0.049) (Table 2). Our goal was to investigate the expression profile of a various oncomiRs and tumor-suppressor miRs in urinary bladder cancer (BC). The data reported here demonstrate that several microRNAs are deregulated in BC through down-regulation. miR-145 was found to be the most down-regulated in bladder cancer compared with normal, and miR-205, miR-210 and miR-21 were the most up-regulated in cancer. miR-21 can be used as independent prognostic factor both for patient survival and metastasis. miR-210 can be used as an independent prognostic factor for overall survival. Table 1. Mean and median fold values, represent the change in the expression levels of the microRNAs, between urinary bladder cancer and normal tissue. *Mann-Whitney U test. microRNAmean foldSDminimummaximumSEMmedian foldp-value* miR-10b miR-19a miR-19b miR miR miR < miR miR miR < miR-296-5p < miR < Figure 2. Kaplan-Meier curve analysis revealed that high miR-21 expression correlated with worse overall survival (p=0.0099). VariableRelative risk95% Confidence IntervalP value Overall SurvivalmiR miR miR RecurrencemiR-19a miR-19b2.1E miR miR MetastasismiR Table 2. Multivariate logistic regression analysis was utilized to assess the potential prognostic factors in overall survival, tumour recurrence and metastasis.